Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: a double-blind, randomized, placebo-controlled study

This publication has 41 references indexed in Scilit:

• Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial
  The Lancet, 2003
• Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes
  Circulation, 2002
• Roxithromycin Treatment Prevents Progression of Peripheral Arterial Occlusive Disease in Chlamydia pneumoniae Seropositive Men
  Circulation, 2002
• Chlamydia pneumoniae Seropositivity Is Associated With Increased Plasma Levels of Soluble Cellular Adhesion Molecules in Community-Dwelling Subjects
  Stroke, 2002
• Inflammation and Atherosclerosis
  Circulation, 2002
• Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non–q-wave acute myocardial infarction
  The American Journal of Cardiology, 2000
• Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Commentary: Adjustment for potential confounders may have been taken too far
  BMJ, 2000
• Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae
  Infection and Immunity, 2000
• Interactions ofChlamydia pneumoniaewith Human Endothelial Cells
  The Journal of Infectious Diseases, 2000
• Chronic infection in the aetiology of atherosclerosis—focus on Chlamydia pneumoniae
  Atherosclerosis, 1999